Resurrecting DNAzymes as sequence-specific therapeutics
- PMID: 22723461
- DOI: 10.1126/scitranslmed.3004080
Resurrecting DNAzymes as sequence-specific therapeutics
Abstract
In a mouse model of skin cancer, intratumoral injection of a sequence-specific mRNA-cleaving DNA enzyme caused potent inhibition of tumor growth and unusually benign pharmacodynamic profiles.
Comment on
-
DNAzyme targeting c-jun suppresses skin cancer growth.Sci Transl Med. 2012 Jun 20;4(139):139ra82. doi: 10.1126/scitranslmed.3003960. Sci Transl Med. 2012. PMID: 22723462
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical